LONDON, England – Researchers at the Francis Crick Institute have discovered that a common dietary supplement could protect against chronic Cryptosporidiosis infections which are particularly prevalent in children under two and in areas with poorer sanitation. Cryptosporidium is a parasite that infects and damages the small intestine. It is one...
Latest News
Ann Arbor, Michigan – For patients with multiple sclerosis, a regular exercise routine is important for managing symptoms. Due to different causes of chronic pain though, physical exercise can be more difficult for some. Research published in the Journal of Pain from the University of Michigan found that widespread pain with nociplastic features,...
Ottawa, Canada – Children and young adults with allergies or eczema who have difficulty swallowing may have eosinophilic esophagitis. A review published in CMAJ (Canadian Medical Association Journal) provides guidance on how to diagnose and manage this chronic inflammatory disease. In people with eosinophilic esophagitis, the esophageal lining is inflamed,...
Osaka, Japan – When people eat, they ingest the nucleic acids that reside in all living things. The compounds in these acids could inhibit the growth of cancer cells, according to findings published in PLOS ONE by Osaka Metropolitan University Associate Professor Akiko Kojima-Yuasa of the Graduate School of Human...
New York, NY – MSK multiple myeloma specialist Sham Mailankody, MBBS has led trials showing that CAR T cell therapy targeting an antigen called GPRC5D appears to be safe and effective against the disease. Results published in the New England Journal of Medicine in September 2022 showed that 71% of patients responded to the GPRC5D-directed...
WATERTOWN, Mass. — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to DISC-3405 for the treatment of...
WATERTOWN, Mass. — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today presented topline data from AURORA, a phase 2 study of bitopertin in patients with EPP. Treatment with bitopertin resulted in statistically...
NEW ORLEANS, Louisiana – During cold and flu season, excess mucus is a common, unpleasant symptom of illness, but the slippery substance is essential to human health. To better understand its many roles, researchers synthesized the major component of mucus, the sugar-coated proteins called mucins, and discovered that changing the...
Montreal, Canada – A McGill-led team of researchers have made an important discovery shedding light on the genetic basis of a rare skeletal disorder. The study, published in Nature Communications, reveals that a defect in a specific gene (heterozygous variants in the matrix Gla protein, or MGP) may cause a...
Göteborg, Sweden – Disrupted function of “cleaning cells” in the body may help to explain why some people with obesity develop type 2 diabetes, while others do not. A study from the University of Gothenburg describes this newly discovered mechanism. It is well known that obesity increases the risk of...